The PepLabo blog
Plain articles on GLP-1 medications, what their labels say about side effects, peptides and keeping a clear record of your own routine. Every article lists its sources.
GLP-1 medications
How semaglutide works
The GLP-1 receptor, appetite, insulin and a one-week half-life, explained from the label.
How semaglutide worksHow tirzepatide works
GIP and GLP-1 receptors, appetite, insulin and a five-day half-life, explained from the labels.
How tirzepatide worksSemaglutide vs tirzepatide
Receptors, approved uses, half-life and the two head-to-head trials, read from the labels and the published papers.
Semaglutide vs tirzepatideOzempic vs Wegovy
Same semaglutide, different approved uses, doses, devices and schedule rules.
Ozempic vs WegovyMounjaro vs Zepbound
Same tirzepatide, same strengths; different approved uses, dose steps and label wording.
Mounjaro vs ZepboundTypes of GLP-1 medications
Active ingredients and brand names side by side: form, schedule and US approved use from each label, plus the EU and Canadian differences.
Types of GLP-1 medicationsGLP-1 pills vs injections
Daily routine, absorption, missed doses, storage and interactions, compared from the labels.
GLP-1 pills vs injectionsWhat is Foundayo?
The once-daily orforglipron tablet: how it works, how it is taken and what its trials showed.
What is FoundayoHow long GLP-1s stay in your system
Half-lives, peak times, steady state and washout for semaglutide, tirzepatide, dulaglutide, liraglutide and orforglipron.
How long GLP-1s stay in your systemWhat the label says about a missed dose
Each GLP-1 label has its own missed-dose and restart rule. Here they are side by side, with the section to check.
A missed GLP-1 doseStoring GLP-1 pens: fridge and room temperature
Fridge and room-temperature limits from each label, product by product, with the dates worth writing down.
Storing GLP-1 pensWhat studies show after stopping a GLP-1
Three trials and two reviews measured what happened when semaglutide, tirzepatide or liraglutide was withdrawn.
After stopping a GLP-1Compounded GLP-1s: what the FDA says
Why compounded semaglutide and tirzepatide are not approved, how the shortage years ended and the risks the FDA lists.
Compounded GLP-1sGLP-1 medications and birth control pills
Why the tirzepatide and orforglipron labels flag the pill, how Europe reads the same data, and what other GLP-1 labels report.
GLP-1s and birth control pillsGLP-1 medications before surgery or a procedure
The aspiration warning in every GLP-1 label, what anesthesia guidance says, and what your care team needs to know.
GLP-1s before surgeryHow long does a GLP-1 take to work?
Drug levels by brand, dose steps, tablets versus injections and the time points measured in STEP 1, SURMOUNT-1 and the labels.
How long a GLP-1 takes to workWhy GLP-1 doses step up
Every label’s starting dose, step length and maintenance options, and what each says when a step is hard to tolerate.
Why GLP-1 doses go up in stepsLiraglutide vs semaglutide
Daily vs weekly, a 13-hour vs one-week half-life, and what the two labels have in common.
Liraglutide vs semaglutideIs semaglutide the same as Ozempic?
Active ingredient, brand and compounded product: three things that often get one name.
Is semaglutide the same as Ozempic?Is tirzepatide the same as Mounjaro?
One active ingredient, two approved brands, and compounded products that are neither.
Is tirzepatide the same as Mounjaro?Who should not take a GLP-1?
Contraindications, "not recommended" situations, pregnancy and age limits, brand by brand from US, EU and Canadian documents.
Who should not take a GLP-1Pregnancy and breastfeeding on GLP-1s
What each US, EU and Canadian document says about pregnancy, breast milk and stopping before a planned pregnancy.
Pregnancy and breastfeeding on GLP-1sWill a GLP-1 show up in blood work?
Lipase, amylase, liver tests and calcitonin: what the labels report about lab values.
GLP-1s and blood workHow GLP-1s can affect other oral medicines
Slower stomach emptying, levothyroxine, warfarin and Foundayo’s liver enzyme interactions, from the labels.
GLP-1s and oral medicinesHow long can you take a GLP-1?
What “long term” means in the labels, the review points in US and EU documents, the longest trials and the reasons to stop.
How long can you take a GLP-1Maintenance: what the trials tested
What “maintenance dosage” means in the labels, brand by brand, and what the continuing groups in SURMOUNT-4, STEP 4 and newer trials showed.
GLP-1 maintenanceWegovy’s heart indication
Who the cardiovascular use covers, how SELECT was run and what its results and footnotes say.
Wegovy heart indicationZepbound and sleep apnea
Who the OSA indication covers, how the two trials were run and what the breathing results showed.
Zepbound and sleep apneaOzempic and chronic kidney disease
Who the kidney indication covers, the two kidney tests behind it and what the FLOW trial found.
Ozempic and kidney diseaseHow a GLP-1 pen works
Pen types, the parts of a dial-a-dose pen and what the Instructions for Use leaflet covers.
How a GLP-1 pen worksHow to read a prescription medicine label
Highlights, the boxed warning, the 17 numbered sections and the patient leaflets, with Wegovy®, Zepbound® and other GLP-1 examples.
Reading a prescription labelWhat a Medication Guide is
When the FDA requires one, how it reaches you and what the Ozempic®, Wegovy®, Mounjaro® and other GLP-1 guides contain, section by section.
What a Medication Guide isTalking to your clinician about weight medicines
Who may benefit, what each label requires and the questions to bring, from the NIDDK, the 2026 labels and FDA pages.
Asking about weight medicinesGLP-1 glossary
Plain definitions of the words in GLP-1 labels, from receptor agonist to eGFR, each taken from an official source.
GLP-1 glossaryWhat GIP is
The gut hormone that tirzepatide is built on: its names, its receptors and what the labels report.
What is GIPAmylin, explained
A hormone released alongside insulin: stomach emptying, glucagon and fullness, from official sources.
Amylin explainedFoundayo™ and Wegovy® tablets compared
Two daily weight tablets, side by side from their US labels: uses, steps, trials and warnings.
Foundayo vs Wegovy tablets503A and 503B compounding
Two sections of US law, two kinds of compounder: who they are, which rules apply, who inspects them and where GLP-1s stand in 2026.
503A vs 503BCounterfeit GLP-1 pens
FDA, EMA, WHO and MHRA notices on fake Ozempic® and Mounjaro® pens: what was found, what to check and where to report.
Counterfeit GLP-1 pensSteady state, explained
Why levels build up over the first weeks, how long each label says it takes, and what “steady” really means.
Steady state, explainedChanging your weekly shot day
The minimum gap each label sets, how to count it, and how to record the move.
Changing your weekly shot dayLipids in GLP-1 trials
LDL, HDL and triglycerides in the weight trials, label by label, and what those averages can and cannot tell you.
Lipids in GLP-1 trialsGLP-1 labels for adolescents
Which products cover young people, from what age and for which condition, what the trials found and what caregivers should know.
GLP-1 labels for adolescentsGLP-1s for type 2 diabetes
Which labels cover type 2 diabetes, for whom, the heart and kidney indications some add, and the trials behind them.
GLP-1s for type 2 diabetesHistory of GLP-1 medicines
From exenatide in 2005 to the 2026 labels, dated from the prescribing information and FDA.
History of GLP-1 medicinesGLP-1 with insulin
What the labels say about combining the two: low blood sugar, injection technique and the eye warning.
GLP-1 with insulinBMI in GLP-1 labels
What BMI is, where the 30 and 27 numbers come from, and how US, EU and Canadian labels use BMI for adults and teens.
BMI in GLP-1 labelsWhat is exenatide?
The oldest GLP-1 medicine in the US labels: where it came from, its two forms, its own warnings and why it left the market.
What is exenatide?Generic liraglutide
Generic Victoza® and Saxenda® copies, what “generic” has to prove, the 2026 shortage picture and why it is not compounded.
Generic liraglutideWegovy and MASH
The fatty liver indication, the biopsy results and what accelerated approval means.
Wegovy and MASHMounjaro and the heart
The 08/2026 label change, the SURPASS-CVOT trial and how to read a result against another medicine.
Mounjaro’s heart indicationSemaglutide tablets and heart risk
The cardiovascular indication of Rybelsus® and Ozempic® tablets, and the four-year trial behind it.
Semaglutide tablets and heart riskFoundayo’s clinical studies
Two 72-week phase 3 trials: who joined, what was measured and how to read the numbers.
Foundayo’s clinical studiesWhat a boxed warning is
When the FDA asks for a box at the top of a label, what goes inside, how the Ozempic® and Foundayo™ boxes compare, and what it does not mean.
What a boxed warning isWhat “off-label” means
Approved uses, unapproved uses of approved medicines, the approved uses of each GLP-1 label and the questions the FDA suggests you ask.
What “off-label” meansHow a medicine gets FDA approval
From discovery to post-market monitoring, with SURPASS, SUSTAIN, the Foundayo™ approval letter and other GLP-1 examples.
How a medicine gets FDA approvalChecking a medicine shortage
How to search the FDA Drug Shortages Database, read a listing and report a new gap, with GLP-1 listings as checked on 20 October 2026.
Checking a medicine shortageWhy injection pens must never be shared
The “never share” warning in Ozempic®, Wegovy®, Mounjaro® and other GLP-1 pen labels, why a new needle is not enough, and what it covers.
Why injection pens must never be sharedGLP-1 insurance terms
What prior authorization, step therapy, formularies, exceptions, appeals and savings cards mean, from official US sources.
GLP-1 insurance termsWhat should a GLP-1 look like?
Clear, colourless or slightly yellow: what the labels say, the “do not use” signs, and why colour cannot prove what is in a vial.
What a GLP-1 should look likeGLP-1 shortages: FDA timeline
When the tirzepatide and semaglutide shortages ended, what the grace periods were, and what the FDA has said since.
GLP-1 FDA timelineIs there a GLP-3?
No human hormone or medicine class goes by that name. What people usually mean, and what the trials of retatrutide show.
What is GLP-3?
Side effects
Nausea on GLP-1 medications
Trial rates against placebo, how long it lasted in trials, what may help and the signs the label says to report.
Nausea on GLP-1 medicationsConstipation on GLP-1 medications
How often it appeared in trials, how long it lasted, what general guidance suggests and what the label asks you to report.
Constipation on GLP-1 medicationsDiarrhea on GLP-1 medications
Rates from the Mounjaro, Zepbound, Ozempic and Wegovy labels, how long it lasted in trials, the dehydration warning and what to log.
Diarrhea on GLP-1 medicationsInjection site reactions
What the labels count, how often it happened against placebo, why rotation matters and the signs that need help.
Injection site reactionsHair loss and GLP-1 medications
Which labels list it, how often, the gap between women and men, whether it grew back in trials and what else can cause it.
Hair loss and GLP-1 medicationsFatigue on GLP-1 medications
Where tiredness appears in the labels, how often against placebo, the warnings that can overlap with it and the other causes worth ruling out.
Fatigue on GLP-1 medicationsGallbladder problems in GLP-1 labels
Gallstone and inflammation rates against placebo, what two meta-analyses found, the weight-loss link and the symptoms to report.
Gallbladder problems in GLP-1 labelsPancreatitis warning on GLP-1 labels
What section 5 says, how rare confirmed cases were in trials, what meta-analyses found and the symptom not to wait on.
Pancreatitis warning on GLP-1 labelsLow blood sugar on GLP-1 medications
Trial rates by situation, why insulin and sulfonylureas change the picture, and the signs the Medication Guides list.
Low blood sugar on GLP-1 medicationsBurping on GLP-1 medications
What “eructation” means in the labels, how often it was reported, and what the labels do not say about sulfur.
Burping on GLP-1 medicationsEye changes in the GLP-1 labels
Diabetic retinopathy complications, the EMA’s NAION finding, what the studies disagree on, and which eye symptoms need care now.
Eye changes in GLP-1 labelsThe GLP-1 thyroid warning
Rodent findings, what studies in people show, who is excluded and the neck symptoms worth reporting.
The GLP-1 thyroid warningGLP-1 and kidney warnings
Why every label ties kidney injury to vomiting, diarrhea and fluid loss, the trial rates, and the signs that need help.
GLP-1 and kidney warningsGLP-1 and heart rate
Average rises of a few beats per minute, the larger changes some people had, and when a racing heart needs a call.
GLP-1 and heart rateHeadache on GLP-1 medications
Which labels list headache, how often it was reported against placebo, and when to get help.
Headache on GLP-1 medicationsDizziness on GLP-1 medications
Label rates against placebo, low blood pressure and fainting, and the warning signs that need a call.
Dizziness on GLP-1 medicationsReflux and heartburn on GLP-1s
GERD, dyspepsia and gastritis in the label tables, compared with placebo, and the signs not to file under heartburn.
Reflux and heartburn on GLP-1sStomach pain on GLP-1 medications
Abdominal pain rates against placebo in each label, and the kinds of pain the labels treat as warning signs.
Stomach pain on GLP-1 medicationsDelayed stomach emptying and GLP-1s
What the labels say about slower emptying, severe stomach reactions and people who already have gastroparesis.
Delayed stomach emptying and GLP-1sMood and depression in GLP-1 labels
The 2026 FDA review, the warning that was removed, and what the labels and the FDA still ask you to report.
Mood and depression in GLP-1 labelsAllergic reactions in GLP-1 labels
The hypersensitivity warning, how often reactions were reported, how they differ from site reactions, and the signs of an emergency.
Allergic reactions in GLP-1 labelsHow long GLP-1 side effects last
Label timing, measured durations from European data, the slower effects and the signs that should not wait.
How long GLP-1 side effects lastGLP-1 label notes for women
Who was in the trials, the side effects reported by sex, what studies add on nausea, and where pill and pregnancy notes live.
GLP-1 label notes for womenSleep problems on GLP-1 medications
One US label lists insomnia; most do not. What else in the labels can reach your nights.
Sleep and GLP-1sDry mouth on GLP-1 medications
Two US labels list it, the EU rates it common for liraglutide, and fluid loss sits close by.
Dry mouth on GLP-1 medicationsLong-term safety: what the trials followed
The two-to-five-year trials, the findings that only appeared with time, and what is still unknown.
Long-term safety in the trialsCancer questions and the GLP-1 labels
The cancer counts in the labels, what large studies found, and why small numbers are easy to over-read.
Cancer questions and GLP-1 labelsBlood pressure changes on a GLP-1
Average falls in the trials, low blood pressure rates against placebo, the role of other blood pressure medicines and the warning signs.
Blood pressure on a GLP-1Gas and bloating on GLP-1s
Flatulence and abdominal distension across nine documents, with placebo beside each figure.
Gas and bloating on GLP-1sTaste changes on GLP-1s
Dysgeusia rates against placebo, how Europe classes it, and what report studies and a small trial add.
Taste changes on GLP-1sHiccups on GLP-1 medicines
Which label names them, what reporting data add, and how to tell an annoying bout from one worth a call.
Hiccups on GLP-1 medicinesBody aches, joint pain and gout
What the labels count, where the signals come from, and the other causes worth ruling out.
Body aches and joint pain on GLP-1sBrain fog on GLP-1 medicines
Not a label term, but the nearby entries, the warning signs and the everyday causes are well described.
Brain fog on GLP-1 medicinesPeeing more on a GLP-1
Not a listed side effect, but the nearby facts help you tell harmless from worth a call.
Frequent urination on a GLP-1Kidney stones and GLP-1 medicines
Two labels report a small excess; other studies point the other way. Here is how to read both.
Kidney stones and GLP-1sTeeth and gums on GLP-1 medicines
Labels say little; the indirect routes through vomiting, reflux and dry mouth are better described.
Teeth and gums on GLP-1sSexual function and GLP-1 medicines
Labels are silent; studies point in different directions. What is known, and how to raise it with a clinician.
Sexual function and GLP-1sBlood clots and GLP-1 medicines
Labels are silent and studies disagree. The warning signs and risk factors are what matter most.
Blood clots and GLP-1 medicinesBad breath on GLP-1 medicines
Not a listed side effect, but its usual sources are. And two specific smells mean more than a mint can fix.
Bad breath on GLP-1 medicines
Peptides
Is tirzepatide a peptide?
Yes. A modified 39-amino-acid chain built on the GIP hormone, read from the US, EU and Canadian documents for Mounjaro® and Zepbound®.
Is tirzepatide a peptide“Research use only” peptides and the FDA
Why “peptide” is not an approval status, what the FDA’s compounding lists say about specific peptides, and the 2026 advisory committee review.
“Research use only” peptidesPeptides on the WADA Prohibited List
The S0, S2 and S4 classes as WADA words them, what changed for 2026, and why a missing name is not permission.
Peptides on the WADA listWhat a peptide is
Amino acid chains, peptide hormones, the sizes of approved peptide medicines and where US rules draw the line with proteins.
What is a peptideWhat reconstitution means
Diluent, mixing, inspection and the clock after mixing, as three approved peptide labels describe them.
What is reconstitutionMulti-dose vials and the 28-day rule
Where the 28 days come from, which labels set their own period and the handling habits the CDC and FDA list.
Multi-dose vials: 28 daysWhat a lyophilized powder is
Freeze-drying explained from an FDA guide, with three approved peptide powders as examples.
Lyophilized powderFDA-approved peptide medicines
Real examples with their labels, the 40-amino-acid line, products on both sides of it, and why approval belongs to a product.
FDA-approved peptide medicinesWhat half-life means
From minutes to a week: what the number on a label measures, what stretches it, and what it does not tell you.
What half-life meansWhat a subcutaneous injection is
The fat layer under the skin, how much medicine reaches the blood from there, and why training on your device comes first.
What a subcutaneous injection isInjection safety basics
What CDC guidance, MedlinePlus and the pen instructions say about needles, vials, clean hands, checking the medicine and when to get help.
Injection safety basicsTherapeutic use exemptions
The four conditions, where to apply, deadlines, decisions, appeals and retroactive TUEs, from WADA’s own pages.
Therapeutic use exemptionsWhat is pramlintide
A mealtime amylin analogue used with insulin: how it acts, who it is for, its boxed warning and its 2026 supply status, from the label.
What is pramlintide
Tracking
How to track side effects on a GLP-1
What each label lists as most common, what one useful entry contains, and which signs the Medication Guides say not to wait on.
Tracking GLP-1 side effectsHow to track a weekly injection
The shot day, pens and vials, and the few details worth logging every week, based on the label.
Tracking a weekly injectionWhere GLP-1 pens are injected
The three areas each label names, how it words rotation and which skin the leaflets say to avoid.
Where GLP-1 pens are injectedTracking weight on a GLP-1 without obsessing
When to weigh, which checkpoints the labels name, and when a fast drop is a reason to call.
Tracking weight on a GLP-1Bringing your log to a GLP-1 appointment
What to bring, what the Medication Guides and labels ask you to mention, and questions worth writing down beforehand.
Your log at a GLP-1 appointmentYour first week on a GLP-1
What the Wegovy® Medication Guide asks you to share, check and watch for, how other labels differ, and a simple log to keep.
Your first week on a GLP-1Keeping a food diary on a GLP-1
What the labels pair the medicine with, when meals and doses meet, what NIDDK says about tracking, and a light format.
A food diary on a GLP-1Body composition: what the scale does not show
Waist results from the labels, what body scan sub-studies found, and a simple way to measure at home.
Body composition beyond the scaleProgress photos: a calm way to take them
A consistent routine, what the Wegovy® and Zepbound® trials say about how results vary, and keeping photos private.
Progress photos on a GLP-1Vials and pens: what changes in your log
Four tirzepatide presentations, how volume, syringes and storage differ, and what to record for each.
GLP-1 vials vs pensLogging on and off cycles
Periods, breaks and repeats in a schedule, and how to read where you are on any day.
Logging on and off cyclesReporting a side effect to the FDA
MedWatch, the consumer form section by section, where other products go, and what happens to a report afterwards.
Reporting a side effect to the FDAExpiry dates and lot numbers
Where to find them on a pen or vial, what they mean, and when you will need them.
Expiry dates and lot numbersYour first month on a GLP-1
Starting doses, the usual timing of side effects, what early trial data show and what is worth writing down.
First month on a GLP-1The 3-month checkpoint
Where the dose ladder stands at week 12, the label and NIDDK response rules, trial data at that point and questions to bring.
3-month GLP-1 checkpoint
Nutrition
Hydration on a GLP-1
No label sets a daily water target. What the nine US labels say about dehydration, kidneys and when to call.
Hydration on a GLP-1Eating when your appetite is low
What the Wegovy®, Zepbound® and Canadian labels, the Dietary Guidelines and a nutrition advisory say, and the signs that need a call.
Eating when your appetite is lowEating on injection day
No special menu in the labels: what they do say about meals, the tablet exceptions, and what nutrition experts suggest for queasy days.
Injection-day eatingOvereating on a GLP-1
Why a big meal can backfire, what the labels and nutrition experts say, other causes to rule out and the signs that need a call.
Overeating on a GLP-1What to eat on a GLP-1
Which food groups the guidance favours, what to limit, where sources disagree and which nutrients can fall short when you eat less.
What to eat on a GLP-1Calories on a GLP-1
No label gives a number. What the trials actually did, why we do not offer a personal target and when eating too little becomes a problem.
Calories on a GLP-1
Lifestyle
Travelling with a GLP-1 pen
Out-of-fridge limits for Ozempic® and other GLP-1 labels, airport screening, sharps on the road and weekly doses across time zones.
Travelling with a GLP-1 penExercise and GLP-1 medications
Activity is written into the approved use. What the trials asked for, the label warnings worth knowing before a workout, and what the guidelines say.
Exercise and GLP-1 medicationsWeight plateaus on a GLP-1
Where the trial curves levelled off, why weight settles, what else can hold it steady, and what to bring to your clinician.
Weight plateaus on a GLP-1Throwing away pens and needles safely
The FDA’s two-step method, what counts as a suitable container, what never goes in the bin, and what the Ozempic® and other pen instructions add.
Throwing away pens and needlesAlcohol and GLP-1 medications
What the Mounjaro® and other labels and MedlinePlus say about drinking, what studies report, and questions to ask.
Alcohol and GLP-1sLean mass in GLP-1 trials
What the labels say about fat and lean mass, what the published body scans measured and what “lean” leaves out.
Lean mass in GLP-1 trialsNot losing weight on a GLP-1
How labels, EU documents and NIDDK set review points, what else can hold weight up, and what to ask.
Not losing weight on a GLP-1Still hungry on a GLP-1
What the Mounjaro®, Wegovy® and other labels say about appetite and cravings, why hunger can persist, and what to ask.
Still hungry on a GLP-1Medicines and surgery
Who each is meant for, how it works, what studies measuring both found, and the risks NIDDK and the labels list.
Medicines and surgery
App guides
What to look for in a GLP-1 tracking app
A checklist built from what the labels ask of you: exact times, rotation, pens and vials, privacy and no dose advice.
Choosing a GLP-1 tracking appTurning your dose history into a report
What a dose history should show, how to tidy it before you share it and what a report is not.
Dose history as a reportDose reminders that reach you
Three alerts per dose, Focus and exact alarms, and a two-minute check that they work.
Dose reminders that reach youUsing the vial shelf
What is left, how many doses, which dates matter, and when the app cannot count.
Using the vial shelfReading the site heat map
What the marks mean, why sizes are relative, and how to fill gaps in your site record.
Reading the site heat mapImporting weight from Apple Health
What is read, how each day is merged with your own entries, and where the data stays.
Importing weight from Apple HealthWhat you can ask PepLabo AI
Questions it answers from your records, what it cannot see, and the ones it always declines.
What you can ask PepLabo AIMeal photo estimates
What the photo estimate does, what leaves your phone and how to fix the numbers before you save.
Meal photo estimatesExporting your data
One file with your doses, vials and logs: how to make it, what is inside and how to restore it.
Exporting your dataWhere your health notes are stored
What stays on your phone, what leaves it and when, and how to switch each part off.
Where your notes are stored
Ozempic®: side effects by symptom
Ozempic® and nausea
The label’s trial numbers, why dose steps matter, the manufacturer’s eating tips and the signs that need a call.
Ozempic® and nauseaVomiting on Ozempic®
How often it happened in each official document, why fluids drive the warnings and what to tell the team before sedation.
Vomiting on Ozempic®Diarrhea on Ozempic®
Three official sets of numbers, a reaction that barely changed with dose, and the fluid warning behind the kidney section.
Diarrhea on Ozempic®Constipation on Ozempic®
An uneven dose pattern, what Europe and Canada add, the rare bowel blockage reports and the signs that need a doctor.
Constipation on Ozempic®Heartburn and indigestion on Ozempic®
Indigestion, reflux, burping and gastritis in three official documents, what a large meta-analysis found and the warning signs.
Ozempic® heartburn and indigestionStomach pain on Ozempic®
How often abdominal pain appeared in three official documents, which pain patterns the label flags and what research adds.
Stomach pain on Ozempic®Injection site reactions with Ozempic®
Three official figures, a placebo surprise, the label’s rotation rule and the signs that point to an allergy instead.
Ozempic® injection site reactionsOzempic® and low blood sugar
Why the risk depends on your other diabetes medicines, with the label’s own tables and the signs to know.
Ozempic® and low blood sugarOzempic® and gallbladder problems
The gallstone figures in three official documents, what two large meta-analyses found and the four symptoms the leaflet names.
Ozempic® and the gallbladderThe Ozempic® pancreatitis warning
Confirmed trial cases, the cardiovascular trial result, enzyme changes, what research shows and the symptom to act on.
Ozempic® and pancreatitisOzempic®, dehydration and the kidney warning
Why a medicine with a kidney-protection indication also carries a kidney injury warning, and what keeps the two apart.
Ozempic® and the kidney warningOzempic® and bloating
Three regulators, three ways of counting a swollen belly, plus the rare signs that point to a blockage.
Ozempic® and bloatingOzempic® and burping
A small but real excess over placebo, a dose pattern that flips between documents, and the reflux connection.
Ozempic® and burpingOzempic® and headache
Why three regulators rate it differently, the two label warnings behind many headaches, and the red flags.
Ozempic® and headacheOzempic® and fatigue
How often tiredness was reported, the label warnings that can feel like it, and the causes worth ruling out.
Ozempic® and fatigueOzempic® and dizziness
Trial rates, the Canadian note on driving during dose increases, and how to tell common causes from urgent ones.
Ozempic® and dizzinessOzempic® and hair loss
Where hair loss sits in the Ozempic® label, what semaglutide studies add and which signs point elsewhere.
Ozempic® and hair lossOzempic® and decreased appetite
How often trials recorded it, what a semaglutide 1 mg study measured, and when a small appetite becomes a problem.
Ozempic® and decreased appetiteOzempic® and taste changes
An uncommon reaction with a precise label name, a trial that found sharper taste, and the many other causes worth ruling out.
Ozempic® and taste changesOzempic® and hiccups
Not in the Ozempic® label, but its burping and reflux figures are. What that means and when hiccups need attention.
Ozempic® and hiccupsOzempic® and brain fog
Not in the labels, yet several listed effects can cloud thinking. How to tell them apart, and what a large diabetes cohort found.
Ozempic® and brain fogOzempic® and body aches
No muscle or joint pain in the label; what large trial analyses show, where muscle loss fits, and the urgent signs.
Ozempic® and body achesOzempic® and insomnia
Not a listed side effect, but reflux, nausea, a faster pulse and night-time lows can all keep you awake.
Ozempic® and insomniaOzempic® and rash
Three kinds of skin reaction, how often each was seen, and the allergy signs that mean stopping and getting help.
Ozempic® and rashOzempic® and dry mouth
Absent from the labels, present in safety reports, and easily confused with thirst from dehydration or high blood sugar.
Ozempic® and dry mouthOzempic® and bad breath
Not in the label, but the burping and reflux rows are. Plus the one breath change that needs urgent care.
Ozempic® and bad breathOzempic® and frequent urination
Not in the label. In type 2 diabetes the usual suspects are blood sugar, other medicines and the bladder itself.
Ozempic® and frequent urinationOzempic® and kidney stones
Not in the Ozempic® label; what semaglutide trials and large record studies found, and how fluid loss fits in.
Ozempic® and kidney stonesOzempic® and your teeth
No dental entry in the label, but vomiting, reflux and dry mouth can reach the teeth. What reviews say and what to tell your dentist.
Ozempic® and your teethOzempic® and sexual function
Diabetes itself is a leading cause of sexual problems. What that means when you wonder about Ozempic®.
Ozempic® and sexual functionOzempic® and blood clots
No clot warning in the label, two meta-analyses pointing different ways, and the warning signs to know.
Ozempic® and blood clotsOzempic® and palpitations
A small average rise in pulse, a Canadian warning the US label does not carry, and the other causes of a pounding heart.
Ozempic® and palpitationsOzempic® and menstrual changes
Not in the label, but reported. How to read the report data, and why a changed cycle matters more with type 2 diabetes.
Ozempic® and menstrual changesOzempic® and mood changes
What the diabetes labels say, what FDA and EMA reviews found, and why low blood sugar belongs on the checklist.
Ozempic® and mood changes
Wegovy®: side effects by symptom
Wegovy® and nausea
Adult, high-dose and teenage trial numbers, how long bouts lasted, comfort steps from the manufacturer and the signs that need a call.
Wegovy® and nauseaWegovy® and vomiting
Why the teenage figure stands out, how long bouts lasted, how the higher dose compares and when fluid loss becomes urgent.
Wegovy® and vomitingWegovy® and diarrhea
Adult and teenage figures, how long bouts lasted, why fluids matter, other causes and the signs that need a doctor.
Wegovy® and diarrheaWegovy® and constipation
Trial rates by pool, why it outlasts the other stomach effects, other causes, self-care from NIH and the signs of a blockage.
Wegovy® and constipationWegovy® and heartburn
Indigestion, reflux and gastritis rows, what large reflux studies found, other causes, NIH self-care and the chest pain that is not heartburn.
Wegovy®, heartburn and indigestionWegovy® and bloating
Distension and flatulence rows in three product documents, the high-dose result, gut conditions that mimic it, NIH’s food triggers and when to call.
Wegovy®, bloating and gasWegovy® and burping
A small rate with a sharp contrast to placebo, what a safety database shows, the swallowed-air steps NIH lists and the signs that need advice.
Wegovy® and burpingWegovy® and stomach pain
How common abdominal pain was in each trial pool, how to tell everyday pain from the label’s warning signs, other causes and home care.
Wegovy® and stomach painWegovy® and headache
Small gaps over placebo in every pool, the dose-step timing, the low blood sugar and fluid links, and the headaches that need urgent care.
Wegovy® and headacheWegovy® and fatigue
How often tiredness and weakness were reported, when they clustered, the overlap with low blood sugar and fluid loss, and other causes to rule out.
Wegovy® and fatigueWegovy® and dizziness
Trial rates, the blood pressure and fainting data, the overlap with low blood sugar and fluid loss, driving, other causes and the emergency signs.
Wegovy® and dizzinessWegovy® and hair loss
Rates at 2.4 mg and 7.2 mg, the split between women and men, the weight-loss link, other causes and when shedding needs a doctor.
Wegovy® and hair lossWegovy® injection site reactions
A low trial rate, the skin changes the label keeps separate, injection technique from the instructions, and the signs of infection or allergy.
Wegovy® injection site reactionsWegovy® and low blood sugar
The type 2 diabetes trial figures, the role of other diabetes medicines, what is known without diabetes, everyday triggers and emergency signs.
Wegovy® and low blood sugarWegovy® and gallbladder problems
Gallstone and inflammation rates for adults and teens, why weight loss alone does not explain them, what meta-analyses found and the symptoms to act on.
Wegovy® and the gallbladderWegovy® and pancreatitis
Confirmed trial cases, a large heart trial with no excess, enzyme changes that are not disease, what studies show, other causes and the signs that mean stop and call.
Wegovy® and pancreatitisWegovy®, dehydration and the kidneys
How stomach side effects connect to a kidney warning, the trial cases, who was more at risk, what the SELECT trial found and what to report.
Wegovy® and the kidneysWegovy® and decreased appetite
Wanting less food is the point of the medicine. Where it tips into a side effect, and what the documents say about that line.
Wegovy® and decreased appetiteWegovy® and taste changes
The label’s dysgeusia figure, EU and Canadian wording, what research measured, and other causes worth ruling out.
Wegovy® and tasteWegovy® and hiccups
Where the US label names hiccups, why no rate is printed, and the reflux link worth knowing about.
Wegovy® and hiccupsWegovy® and brain fog
Not in the label. The tiredness, blood sugar and blood pressure effects that can feel like it, and the warning signs.
Wegovy® and brain fogWegovy® and body aches
Why muscle and joint pain are missing from the label, what “dysesthesia” means, and the knee trial that went the other way.
Wegovy® and body achesWegovy® and insomnia
Not in the label tables. What the research says, which label effects can disturb a night, and when to get help.
Wegovy® and insomniaWegovy® and rash
Teen trial rates, the allergy warning, redness where you inject, and the signs that need emergency care.
Wegovy® and rashWegovy® and dry mouth
Absent from the label, present in reports. Fluids, saliva and the dental side worth knowing.
Wegovy® and dry mouthWegovy® and bad breath
What the Wegovy® tables show near the mouth, three likely sources of odour, and when a smell is a warning sign.
Wegovy® and bad breathWegovy® and frequent urination
Not in the label, yet several Wegovy® facts touch the bladder. Which ones, and which urine changes need a call.
Wegovy® and frequent urinationWegovy® and kidney stones
The one trial figure on the label, what it can and cannot tell you, and how to recognise a stone.
Wegovy® and kidney stonesWegovy® and dental problems
No dental entry in the label, but plenty of acid exposure. What researchers know, what they do not, and the dental visit checklist.
Wegovy® and dental problemsWegovy® and sexual function
Not in the label, but asked about constantly. What studies in people without diabetes show, what they cannot, and how to raise it.
Wegovy® and sexual functionWegovy® and blood clots
Fewer heart attacks and strokes in SELECT, a different question for leg and lung clots. What is known about each.
Wegovy® and blood clotsWegovy® and palpitations
What the heart rate warning measured, how the EU and Canada describe it, and the signs that cannot wait.
Wegovy® and palpitationsWegovy® and menstrual changes
Not in the label tables. Animal and PCOS findings, the pregnancy rules, and the signs worth a call.
Wegovy® and periodsWegovy® and mood changes
The 2026 label change, trial data on depression and anxiety, and the signs that need help today.
Wegovy® and mood
Wegovy® tablets: side effects by symptom
Wegovy® tablets and low blood sugar
What the label does and does not report on hypoglycemia for the daily tablet, who it concerns most and when to get help.
Wegovy® tablets and low blood sugarWegovy® tablets and the gallbladder
The gallstone figures reported for the daily tablet, what they cannot tell you, and the symptoms that need a call.
Wegovy® tablets and gallstonesWegovy® tablets and the kidney warning
How fluid loss from stomach side effects connects to the kidney warning, with the tablet trial’s own numbers and the signs to act on.
Wegovy® tablets and kidneysWegovy® tablets and nausea
Tablet-specific trial numbers, the weeks most likely to bring it on, what the empty-stomach routine does and does not do, and the signs that need a call.
Wegovy® tablets and nauseaVomiting on Wegovy® tablets
The tablet trial’s own vomiting figures, what happens with a tablet you bring back up, why fluid loss matters and which signs cannot wait.
Wegovy® tablets and vomitingWegovy® tablets and diarrhea
The tablet trial’s diarrhea figures, why they look lower than the injection’s, telling the tablet apart from a stomach bug, and dehydration warning signs.
Wegovy® tablets and diarrheaConstipation on Wegovy® tablets
The one stomach effect the EU documents call longer-lasting: tablet trial figures, the rare serious end, other causes and how self-care fits the morning routine.
Wegovy® tablets and constipationWegovy® tablets and heartburn
Indigestion and reflux figures from the 25 mg tablet trial, acid remedies around the morning dose, and the chest symptoms that need urgent care.
Wegovy® tablets and heartburnWegovy® tablets and bloating
Why the 25 mg tablet trial has no bloating figure, what nearby data show, and the signs that turn a swollen belly into a call.
Wegovy® tablets and bloatingWegovy® tablets and burping
The registry count from the 25 mg tablet trial, how it compares with other data, likely reasons and the signs that need a call.
Wegovy® tablets and burpingWegovy® tablets and stomach pain
Tablet trial figures for belly pain, the four kinds of pain the label treats as warnings, and when to call or go to emergency care.
Wegovy® tablets and stomach painWegovy® tablets and headache
The tablet trial’s headache figures, why the US label points to an injection table, the morning pain-reliever question and the headaches that need help fast.
Wegovy® tablets and headacheWegovy® tablets and fatigue
Two tablet figures that look like they disagree, when tiredness tends to appear, label warnings that can feel similar and everyday causes worth checking.
Wegovy® tablets and fatigueWegovy® tablets and dizziness
How often tablet users felt dizzy, what the EU leaflet says about the first months and driving, the blood pressure and fluid links, and which signs need help now.
Wegovy® tablets and dizzinessWegovy® tablets and hair loss
The tablet trial’s hair loss rate, how it compares with injection figures, what is known about recovery and weight loss, and other reasons hair thins.
Wegovy® tablets and hair lossWegovy® tablets and decreased appetite
Where appetite loss stops being the intended effect and becomes a reported side effect, with the tablet trial’s own figures.
Wegovy® tablets and decreased appetite
Rybelsus®: side effects by symptom
Rybelsus® and nausea
US, EU and Canadian rates, the starter month, the tablet’s morning routine, self-care from general sources and when to call.
Rybelsus® and nauseaRybelsus® and vomiting
Rates in three countries, the gap in the label about a tablet that comes back up, dehydration and the signs that cannot wait.
Rybelsus® and vomitingRybelsus® and diarrhea
Rates in US, EU and Canadian product information, who was studied, rehydration with diabetes, other causes and warning signs.
Rybelsus® and diarrheaRybelsus® and constipation
Why the lower strength scores higher, what is known about blockages, everyday causes, self-care and how to fit fibre or laxatives around the tablet.
Rybelsus® and constipationRybelsus® and heartburn
Reflux, indigestion and gastritis rates, what a meta-analysis adds, how antacids fit around the tablet, other triggers and when it is not heartburn.
Rybelsus® and heartburnRybelsus® and bloating
Swelling and gas rates in the US, EU and Canada, bloating versus distension, everyday causes including other diabetes tablets, and what NIH suggests.
Rybelsus® and bloatingRybelsus® and stomach pain
How often it happens, the three label warnings that start with pain, what real-world reports show, other causes, mild-pain home care and emergency signs.
Rybelsus® and stomach painRybelsus® and decreased appetite
The widest gap from placebo in the table, how Europe explains it, trial weight changes, low blood sugar with other diabetes medicines and other causes.
Rybelsus® and decreased appetiteRybelsus® and low blood sugar
Trial results by background medicine, why insulin and sulfonylureas change the picture, warning signs, night-time and driving, and emergency signs.
Rybelsus® and low blood sugarRybelsus® and the gallbladder
Trial and label figures, a four-year outcome trial, what larger analyses of GLP-1 medicines show, who is at risk anyway, attack symptoms and when to call.
Rybelsus® and the gallbladderRybelsus® and pancreatitis
Trial counts in three countries, outcome-trial and meta-analysis results, why reports still stand out, the pain to recognise, other causes and the steps the label sets.
Rybelsus® and pancreatitisRybelsus® and the kidneys
The dehydration warning in three countries, what long trials found for kidney outcomes, use with kidney disease, other causes of kidney injury and the signs to report.
Rybelsus® and the kidneysRybelsus® and burping
Three product documents, two drug-safety databases, and the burping that should not be shrugged off.
Rybelsus® and burpingRybelsus® and headache
A small gap over placebo, two label warnings that can show up as head pain, and a morning routine worth noting.
Rybelsus® and headacheRybelsus® and fatigue
Why the US label is silent, what Canada’s table counted, and the label warnings that can leave you drained.
Rybelsus® and fatigueRybelsus® and dizziness
Mixed trial numbers, a clear timing note about dose increases, and the dizzy spells that are emergencies.
Rybelsus® and dizzinessRybelsus® and hair loss
One line in the US label, silence in Europe and Canada, and why shedding often has another explanation.
Rybelsus® and hair lossRybelsus® and taste changes
Two regulators, two frequency bands, and the metallic taste that can signal something urgent.
Rybelsus® and taste changesRybelsus® and hiccups
Why the tablet labels are silent, what reports of semaglutide show, and when hiccups stop being a nuisance.
Rybelsus® and hiccupsRybelsus® and brain fog
Not on any label, studied in two large memory trials, and easy to confuse with low blood sugar.
Rybelsus® and brain fogRybelsus® and body aches
What the labels do and do not list, a skin-sensation effect at higher doses, and the aches that need a call.
Rybelsus® and body achesRybelsus® and insomnia
Not in any label, no higher risk in a large cohort, and two label effects that can wake you at night.
Rybelsus® and insomniaRybelsus® and rash
An uncommon allergic reaction, a tingling skin sensation that is not a rash, and the signs that mean stop and get help.
Rybelsus® and rashRybelsus® and dry mouth
Absent from the labels, present in reports, and tied to a fluid warning that matters on a daily tablet.
Rybelsus® and dry mouthRybelsus® and bad breath
Not listed itself, linked to reflux and burping that are, and three smells that need urgent attention.
Rybelsus® and bad breathRybelsus® and frequent urination
Not a listed side effect, but a useful clue about blood sugar, other medicines or an infection.
Rybelsus® and peeing moreRybelsus® and kidney stones
Not a listed side effect, mixed evidence for semaglutide, and a water rule that is easy to misread.
Rybelsus® and kidney stonesRybelsus® and dental problems
No listed dental side effect, indirect routes through the stomach, and two tablet details your dentist should know.
Rybelsus® and teethRybelsus® and sexual function
Not a listed side effect, a common problem in type 2 diabetes, and the other medicines that often sit beside the tablet.
Rybelsus® and sexRybelsus® and blood clots
Not a listed side effect, mixed trial evidence, and a specific note for anyone who already takes warfarin.
Rybelsus® and blood clotsRybelsus® and palpitations
A pulse rise of a few beats, a Canadian ECG note, and how to tell a harmless flutter from a warning sign.
Rybelsus® and palpitationsRybelsus® and periods
No listed cycle effect, reporting signals for semaglutide, and the tablet’s own rules on contraception, pregnancy and breastfeeding.
Rybelsus® and periodsRybelsus® and mood
Not a listed side effect, a low-sugar sign worth knowing, and a trial of the tablet in people with depression.
Rybelsus® and mood
Mounjaro®: side effects by symptom
Mounjaro® and nausea
Rates from three regulators, the dose-step pattern, other causes, what may help and when to call.
Mounjaro® and nauseaMounjaro® and vomiting
Adult, pediatric and heart-trial rates, why fluids and blood sugar matter, and when vomiting is urgent.
Mounjaro® and vomitingMounjaro® and diarrhea
Dose-level rates from three regulators, the placebo baseline, metformin, kidneys and when to call.
Mounjaro® and diarrheaMounjaro® and constipation
Trial rates from three regulators, the long heart trial, blockage reports, other causes and self-care.
Mounjaro® and constipationMounjaro®, heartburn and indigestion
Dyspepsia, reflux and burping in two trial pools, the slower stomach, night-time reflux and warning signs.
Mounjaro® and heartburnMounjaro® and stomach pain
How often it was reported, who reported more, which pain is a warning sign and what eases mild pain.
Mounjaro® and stomach painMounjaro® and injection site reactions
Trial rates in four populations, the antibody link, why sites are rotated and when a reaction stops being local.
Mounjaro® injection site reactionsMounjaro® and decreased appetite
Rates by dose, why tirzepatide curbs hunger, when eating less goes too far and what to tell your prescriber.
Mounjaro® and decreased appetiteMounjaro® and low blood sugar
Rates on its own and with other diabetes medicines, in adults and children, what raises the risk and what to do.
Mounjaro® and low blood sugarMounjaro® and gallbladder problems
The section 5.8 warning, trial and meta-analysis data, the weight-loss link and the symptoms to report.
Mounjaro® and gallbladderMounjaro® and pancreatitis
The warning in three regions, confirmed cases, what meta-analyses found, enzyme rises and the pain that means stop and call.
Mounjaro® and pancreatitisMounjaro®, dehydration and the kidneys
The fluid-loss warning, guidance for kidney disease, what kidney analyses found and the signs to act on.
Mounjaro® and the kidneysMounjaro® and bloating
A swollen belly and wind in three sets of product information, the slower stomach and when to call.
Mounjaro® and bloatingMounjaro® and burping
Eructation rates in diabetes trials, report signals, the slower stomach and when a burp is not just a burp.
Mounjaro® and burpingMounjaro® and headache
No label row and no excess in trials, yet reports exist. Triggers to check and red flags.
Mounjaro® and headacheMounjaro® and fatigue
Up to 4% in placebo trials, 10% in the long heart trial, and the causes worth ruling out.
Mounjaro® and fatigueMounjaro® and dizziness
Common in the EU label, raised in a trial meta-analysis, and three causes to check first.
Mounjaro® and dizzinessMounjaro® and hair loss
A postmarketing entry in the US, “common” in the EU, and what tirzepatide studies add.
Mounjaro® and hair lossMounjaro® and taste changes
A rare listed reaction, what report studies show, other diabetes medicines and practical steps.
Mounjaro® and taste changesMounjaro® and hiccups
Not on any tirzepatide label, but burping and reflux are. What that means and when to call.
Mounjaro® and hiccupsMounjaro® and brain fog
Not a labelled effect, but several labelled problems can cloud thinking. How to sort them.
Mounjaro® and brain fogMounjaro® and body aches
No muscle or joint pain row, an uncommon skin-sensation entry, and when aches are urgent.
Mounjaro® and body achesMounjaro® and insomnia
Not a labelled side effect, but night lows, reflux and a few studies are worth knowing.
Mounjaro® and insomniaMounjaro® and rash
Hives, eczema and itching beyond the injection site, the ingredient question and emergency signs.
Mounjaro® and rashMounjaro® and dry mouth
Not on the Mounjaro® labels, 1% in tirzepatide weight trials, and why thirst matters.
Mounjaro® and dry mouthMounjaro® and bad breath
Not on the labels, but burping, reflux and vomiting are, and fruity breath in diabetes is an emergency sign.
Mounjaro® and bad breathMounjaro® and frequent urination
Not on the labels. The usual causes in diabetes care, kidney data, and when to call.
Mounjaro® and frequent urinationMounjaro® and kidney stones
Not a listed side effect; trial pools, urine chemistry, dehydration and the signs of a passing stone.
Mounjaro® and kidney stonesMounjaro® and dental problems
No label entry, a diabetes cohort on gums and extractions, acid exposure and the sedation warning.
Mounjaro® and dental problemsMounjaro® and palpitations
A small average rise in heart rate, more racing episodes at higher doses, and the causes to rule out.
Mounjaro® and palpitationsMounjaro® and menstrual changes
No label entry, an animal cycle finding, a report signal, PCOS data and why a missed period needs a test.
Mounjaro® and periodsMounjaro® and mood changes
Three regulators, three wordings; what studies in diabetes show, low blood sugar and crisis help.
Mounjaro® and mood changes
Zepbound®: side effects by symptom
Zepbound® and nausea
Rates from three regulators, the step-up timing, whether nausea tracks weight loss and the signs to report.
Zepbound® and nauseaZepbound® and vomiting
A row that rises with every dose, the fluid and kidney warnings behind it, and what helps.
Zepbound® and vomitingZepbound® and diarrhea
Weight-trial and diabetes-trial rates side by side, fluids and electrolytes, remedies and the signs that need a doctor.
Zepbound® and diarrheaZepbound® and constipation
The one stomach row that falls as the dose rises, the sleep apnea picture, and when constipation is more than a nuisance.
Zepbound® and constipationZepbound® and heartburn
Reflux and indigestion as two separate label rows, the bedtime angle, and chest signs that need a doctor.
Zepbound® and heartburnZepbound® and bloating
Two small label rows, the constipation row beside them, and the swollen belly that needs prompt care.
Zepbound® and bloatingZepbound® and burping
A small row with a big gap from placebo, the sulfur question, and when belching points to a slow stomach.
Zepbound® and burpingZepbound® and stomach pain
The common ache in the trial table, the pain patterns that point elsewhere, and who to call.
Zepbound® and stomach painZepbound® and fatigue
What the fatigue row counts, three label-described routes to tiredness, and what sleep apnea data add.
Zepbound® and fatigueZepbound® and hair loss
Three regulators’ figures, the gap between women and men, shedding after weight loss and what to check.
Zepbound® and hair lossZepbound® injection site reactions
Rates from three regulators, the antibody link, device-by-device instructions and the line between a local reaction and allergy.
Zepbound® injection site reactionsZepbound® and low blood sugar
Trial rates with and without diabetes, the medicines that raise the risk, warning signs and planning ahead.
Zepbound® and low blood sugarZepbound® and the gallbladder
Stone, inflammation and surgery rates from three regulators, the weight-loss link and the warning signs.
Zepbound® and the gallbladderZepbound® and pancreatitis
Three trial programmes that do not agree, enzyme results, past pancreatitis and the signs to act on.
Zepbound® and pancreatitisZepbound® and the kidneys
How fluid loss leads to the kidney warning, trial figures, existing kidney disease and what SURMOUNT measured.
Zepbound® and the kidneysZepbound® and headache
Not a labelled reaction, yet three label warnings and untreated sleep apnea can all end in a headache.
Zepbound® and headacheZepbound® and dizziness
A labelled reaction with a blood pressure story behind it, plus fluid loss and low sugar to rule out.
Zepbound® and dizzinessZepbound® and decreased appetite
The effect the medicine is built around, the point where it turns into a problem, and what to note down.
Zepbound® and decreased appetiteZepbound® and taste changes
An uncommon but recorded reaction. Dry mouth, smell and a smaller diet can all play a part.
Zepbound® and taste changesZepbound® and hiccups
No tirzepatide document lists hiccups, but burping and reflux, which can set them off, are clearly raised.
Zepbound® and hiccupsZepbound® and brain fog
No label names it, but several Zepbound®-specific situations can cloud thinking. How to sort them out.
Zepbound® and brain fogZepbound® and body aches
Not a labelled reaction, but sore injection sites, odd skin sensations and fluid loss can feel like aches.
Zepbound® and body achesZepbound® and insomnia
Not a listed reaction, and the sleep apnea trials improved sleep. What can still keep you awake.
Zepbound® and insomniaZepbound® and rash
Allergic-type skin reactions by dose and timing, what differs between pens and vials, and the signs that mean stop.
Zepbound® and rashZepbound® and dry mouth
Uncommon but recorded in the US and Canadian documents; often a clue to fluid loss rather than a problem in itself.
Zepbound® and dry mouthZepbound® and bad breath
Not a labelled side effect, but several neighbouring ones are; the odours that mean more than a mouth problem.
Zepbound® and bad breathZepbound® and frequent urination
Not in any tirzepatide label. More fluids, night-time sleep apnea and urinary infections are the usual suspects.
Zepbound® and frequent urinationZepbound® and kidney stones
Not a listed side effect, but fluid loss is; what tirzepatide studies found and how to tell stone pain from other warnings.
Zepbound® and kidney stonesZepbound® and dental problems
Not a listed side effect; acid, saliva, sedation and sleep apnea are the reasons your dentist should still know.
Zepbound® and dental problemsZepbound® and sexual function
Not a labelled side effect; mixed early studies, the sleep apnea connection and the listed effects that can get in the way.
Zepbound® and sexual functionZepbound® and blood clots
Not a listed side effect; what large records studies and SURMOUNT-1 blood tests show, and why obesity matters more.
Zepbound® and blood clotsZepbound® and palpitations
A small average rise in heart rate, a minority with bigger changes, and the listed effects that can make the heart race.
Zepbound® and palpitationsZepbound® and menstrual changes
Not a listed side effect; what animal data, report databases and PCOS studies show, and why a late period means a pregnancy test.
Zepbound® and menstrual changesZepbound® and mood changes
The US label dropped its suicide warning in 2026; Canada kept a monitoring note. What the trials found and what to watch.
Zepbound® and mood changes
Saxenda®: side effects by symptom
Saxenda® and nausea
Adult and teen rates from three regulators, the five-week climb, the trial findings and the warning signs.
Saxenda® and nauseaSaxenda® and vomiting
Four times the placebo rate in adults and far higher in teens. Fluids, kidneys, surgery and the signs that cannot wait.
Saxenda® and vomitingSaxenda® and diarrhea
One adult in five in the trials. The kidney link, the effect on tablets, other causes and when to call.
Saxenda® and diarrheaSaxenda® and constipation
One adult in five in the trials, far fewer teens. What drives it, what else to rule out and when it needs urgent care.
Saxenda® and constipationSaxenda® and heartburn
Reflux and indigestion are both listed. The slower stomach, other triggers, self-care steps and the chest pain that is not heartburn.
Saxenda® and heartburnSaxenda® and bloating
Distension and wind are both listed. Slower digestion, diet triggers, what NIH sources suggest and the warning signs.
Saxenda® and bloatingSaxenda® and burping
Uncommon in absolute terms, yet more than twenty times the placebo rate. The likely reasons, swallowed air and reflux.
Saxenda® and burpingSaxenda® and stomach pain
Ordinary aches and indigestion are common; a few pains point to pancreatitis, gallbladder disease or a blocked bowel.
Saxenda® and stomach painSaxenda® and headache
Frequent, but barely above placebo. The label effects that can trigger one, pain relievers and red flags.
Saxenda® and headacheSaxenda® and fatigue
Listed in all three labels and concentrated in the first 12 weeks. What drives it, what else to check and when to call.
Saxenda® and fatigueSaxenda® and dizziness
Modest in adults, larger in teens, mostly in the first three months. The label effects behind it and what the regulators say about driving.
Saxenda® and dizzinessSaxenda® injection site reactions
Redness, itching and small rashes at a daily injection site; the lumps the label warns about, technique and allergy signs.
Saxenda® injection site reactionsSaxenda® and low blood sugar
Rare without diabetes medicines, real with them, and more common in teens. The data by group, signs and treatment basics.
Saxenda® and low blood sugarSaxenda® and the gallbladder
A label warning, not just a side effect. Trial rates, what studies show about bile flow, symptoms and who to call.
Saxenda® and the gallbladderSaxenda® and pancreatitis
Rare but serious and in every label. The confirmed trial cases, the gallstone link, what lipase rises mean and the pain to act on.
Saxenda® and pancreatitisSaxenda® and the kidneys
Not a direct kidney toxin in the labels, but a dehydration risk. Reports, who is more exposed, warning signs and fluids.
Saxenda® and the kidneysSaxenda® and hair loss
Listed after approval, absent from the trial tables. Reports, the weight-loss link, timing and warning signs.
Saxenda® and hair lossSaxenda® and decreased appetite
The intended effect, how often it was reported, what studies measured and the signs that eating has dropped too far.
Saxenda® and low appetiteSaxenda® and taste changes
A listed, mostly early and mild reaction. The figures, possible links with nausea and dry mouth, and one taste that is a warning sign.
Saxenda® and taste changesSaxenda® and brain fog
Absent from the labels. The nearby reactions that can blur thinking, what trials of liraglutide measured, and when confusion is urgent.
Saxenda® and brain fogSaxenda® and body aches
A teen table row and a Canadian footnote. Everyday causes, the pains that are not muscular, and when to get help.
Saxenda® and body achesSaxenda® and insomnia
In all three labels, slightly above placebo and mostly early. The likely reasons, other causes and when sleep problems need a doctor.
Saxenda® and insomniaSaxenda® and rash
Three different things called a rash: injection-site reactions, rash elsewhere, and allergy. Figures and warning signs.
Saxenda® and rashSaxenda® and dry mouth
A listed, low-rate reaction. Why it may happen, which other medicines dry the mouth, and how it affects teeth and taste.
Saxenda® and dry mouthSaxenda® and bad breath
Not a listed side effect, but several listed ones can change your breath. The label lines, a database signal, other causes and what helps.
Saxenda® and bad breathSaxenda® and frequent urination
Not listed as such, but urinary infections were a little more common. The kidney warning, the sodium studies, other causes and red flags.
Saxenda® and frequent urinationSaxenda® and your teeth
No dental entry in the Saxenda® labels, a toothache entry for the same molecule, and listed reactions that wear on enamel. What dentists and NIDCR advise.
Saxenda® and your teethSaxenda® and sexual function
Nothing listed in the labels, small studies in men that point the other way, little data for women. The label effects that can still get in the way.
Saxenda® and sexual functionSaxenda® and blood clots
No clot warning in any Saxenda® document. What the GLP-1 meta-analyses and liraglutide studies show, the warfarin note and the signs of DVT and PE.
Saxenda® and blood clotsSaxenda® and palpitations
Heart rate increase is a formal warning for Saxenda®. The trial numbers, the heart rhythm notes, other causes and who to call.
Saxenda® and palpitationsSaxenda® and your period
Not a listed side effect. Liraglutide trials in PCOS, the pregnancy rules, what was seen in teenagers and the cycle changes worth reporting.
Saxenda® and your periodSaxenda® and mood changes
The 2026 US label change, the Canadian warning that remains, what liraglutide trials measured, and urgent help.
Saxenda® and mood
Victoza®: side effects by symptom
Victoza® and nausea
Trial rates from three regulators, why the first weeks are hardest and which signs mean a call.
Victoza® and nauseaVictoza® and vomiting
Rates by dose, the trials behind them, why the label links vomiting to the kidneys and when to call.
Victoza® and vomitingVictoza® and diarrhea
Rates from three regulators, what the trials say about dose, effects on tablets and the signs that need a call.
Victoza® and diarrheaVictoza® and constipation
How often it shows up, what the rare serious bowel reports say and the signs that cannot wait.
Victoza® and constipationVictoza® and heartburn
Indigestion, reflux and gastritis in the label data, what research adds and the chest symptoms to take seriously.
Victoza® and heartburnVictoza® and headache
Trial rates next to placebo and other diabetes medicines, two causes worth checking and the red flags.
Victoza® and headacheVictoza® injection site reactions
How often skin reactions happened, why lumps matter, how to tell allergy from soreness and what the pen instructions say.
Victoza® injection site reactionsVictoza® and decreased appetite
How often appetite drops, what studies in type 2 diabetes measured and why skipped meals matter with insulin or a sulfonylurea.
Victoza® and decreased appetiteVictoza® and low blood sugar
Adult rates by combination, the higher risk in young people, the LEADER results and what to do in a low.
Victoza® and low blood sugarVictoza® and gallbladder problems
Why short and long trials disagree, how serious the events were, what research adds and which symptoms to act on.
Victoza® and gallbladder problemsVictoza® and pancreatitis
The trial cases, what LEADER found, how to read enzyme results and the pain that means stop and call.
Victoza® and pancreatitisVictoza® and the kidneys
Why the label links stomach reactions to kidney injury, use with kidney disease and what the LEADER renal results show.
Victoza® and the kidneysVictoza® and bloating
Swelling, fullness and wind on liraglutide: the European class, Canadian trial rows and the warning signs.
Victoza® and bloatingVictoza® and burping
Canada lists burping as common; the US and EU do not. The indigestion and reflux rows that explain it.
Victoza® and burpingVictoza® and stomach pain
Usually part of the early digestive effects, but the label also names two organ problems that start with pain.
Victoza® and stomach painVictoza® and fatigue
Listed as common in Europe, absent from the US table, and easy to confuse with blood sugar swings.
Victoza® and fatigueVictoza® and dizziness
Common in European data, a heart-rate note in Canada, and low blood sugar as the cause to check first.
Victoza® and dizzinessVictoza® and hair loss
Reported after approval, without a rate; reviews put liraglutide at the lower end among GLP-1 medicines.
Victoza® and hair lossVictoza® and taste changes
An uncommon, listed reaction with no trial rate, and a few practical points for people managing diabetes.
Victoza® and taste changesVictoza® and hiccups
Not listed for liraglutide anywhere; the nearest label rows are indigestion, reflux and burping.
Victoza® and hiccupsVictoza® and brain fog
Not a listed reaction; blood sugar in either direction is the first thing the sources point to.
Victoza® and brain fogVictoza® and body aches
Back pain makes the US table by a small margin; muscle and joint rows sit close to placebo.
Victoza® and body achesVictoza® and insomnia
Not a listed Victoza® reaction; night-time blood sugar and reflux are the label-linked routes to check.
Victoza® and insomniaVictoza® and rash
Three kinds of skin reaction on liraglutide, what each document counts, and when a rash is an emergency.
Victoza® and rashVictoza® and dry mouth
Not a listed Victoza® reaction; fluid loss and blood sugar are the label-linked routes to check.
Victoza® and dry mouthVictoza® and frequent urination
Not a listed reaction; the urinary infection rows, sodium studies and diabetes causes that explain most cases.
Victoza® and frequent urinationVictoza® and dental problems
What the toothache listing means, how type 2 diabetes affects the mouth, and what to tell your dentist.
Victoza® and dental problemsVictoza® and sexual function
What the labels list, what small liraglutide studies found, and how type 2 diabetes affects sex for men and women.
Victoza® and sexual functionVictoza® and blood clots
What the labels say, what trial and real-world analyses found for GLP-1 medicines, and the signs of a clot.
Victoza® and blood clotsVictoza® and palpitations
What the US, EU and Canadian documents say about pulse, rhythm and ECG changes on liraglutide.
Victoza® and palpitationsVictoza® and menstrual changes
What the labels say, what liraglutide studies in PCOS found, and why pregnancy comes first with a late period.
Victoza® and menstrual changesVictoza® and mood changes
No psychiatric warning on the Victoza® label; low blood sugar and living with diabetes are the routes to know.
Victoza® and mood changes
Trulicity®: side effects by symptom
Trulicity® and nausea
Rates from three regulators, the early peak and how it fades, severity, and the signs that need a call.
Trulicity® and nauseaVomiting on Trulicity®
Dose-by-dose rates from three regulators, how few stopped, and when vomiting needs care the same day.
Trulicity® and vomitingTrulicity® and diarrhea
Rates against placebo, a plateau above 3 mg, other causes in diabetes, and the signs that need a call.
Trulicity® and diarrheaTrulicity® and constipation
US, EU and Canadian figures, what blockage reports mean, everyday causes, self-care and the signs that need a same-day call.
Trulicity® and constipationTrulicity®, heartburn and reflux
Reflux, indigestion and excess acid in the US, EU and Canadian data, what safety databases show, the anaesthesia warning and the signs that need urgent care.
Trulicity® and heartburnTrulicity®, bloating and gas
Swelling, wind and burps in the US, EU and Canadian data, one trial where burping stood out, everyday causes and when a swollen belly needs care.
Trulicity® and bloatingTrulicity® and stomach pain
What the pain row counts in US, EU and Canadian data, how location and pattern help, everyday causes, easing mild pain and the signs that cannot wait.
Trulicity® and stomach painFatigue on Trulicity®
A small excess in trials, few studies, and the medicine-related and everyday reasons you might feel drained.
Trulicity® and fatigueInjection-site reactions with Trulicity®
Uncommon in adults, more frequent in children, and how to tell a bruise from an infection or an allergy.
Trulicity® injection-site reactionsTrulicity® and decreased appetite
A side effect with a very low placebo rate, what the weight data show, and keeping meals regular.
Trulicity® and decreased appetiteTrulicity® and low blood sugar
Why the medicine taken alongside it matters more than the Trulicity® dose, and how three regulators count a low.
Trulicity® and low blood sugarTrulicity® and gallbladder problems
A small gap over five years in REWIND, what later studies added, and the four signs to report.
Trulicity® and the gallbladderTrulicity® and pancreatitis
Rare in trials, serious when it happens: the case counts, the enzyme question and what to do if the pain starts.
Trulicity® and pancreatitisTrulicity® and the kidneys
A short-term warning about dehydration, longer-term trial findings, and how the two fit together.
Trulicity® and the kidneysTrulicity® and burping
Eructation rates from three regulators, the trial where it was most frequent, the reflux link and warning signs.
Trulicity® and burpingTrulicity® and headache
Why the US table leaves it out, the numbers the Canadian monograph publishes, and the label effects that can bring one on.
Trulicity® and headacheTrulicity® and dizziness
Only one regulator gives it a number. The listed effects that can make you light-headed, and the signs that need help today.
Trulicity® and dizzinessTrulicity® and hair loss
Named in reports after approval, never given a rate. How dulaglutide compares in safety databases and why hair sheds months later.
Trulicity® and hair lossTrulicity® and taste changes
All three regulators mention altered taste, none with a percentage. How rare it is, what else changes taste, and why it matters with diabetes.
Trulicity® and taste changesTrulicity® and brain fog
Absent from every Trulicity® side-effect list. The listed effects that cloud thinking, a five-year look at cognition, and when confusion is urgent.
Trulicity® and brain fogTrulicity® and body aches
Joint, back and limb pain were counted in trials and came out close to the comparison groups. What else explains aching, and the pain that is urgent.
Trulicity® and body achesTrulicity® and insomnia
Barely different from placebo in trials, yet flagged in reporting databases. The label effects that can disturb a night, and what sleep guidance says.
Trulicity® and insomniaTrulicity® and rash
Rare but named in every label. How to tell a local reaction from an allergic one, what case reports describe, and the signs that mean emergency care.
Trulicity® and rashTrulicity® and dry mouth
One Canadian listing, the dehydration warnings, high blood sugar as a cause and the signs that need care the same day.
Trulicity® and dry mouthTrulicity® and kidney stones
Counts from the Canadian trial table, what they can and cannot show, the dehydration warnings and the symptoms of a stone.
Trulicity® and kidney stonesTrulicity® and sexual function
What the labels leave out, what a five-year trial found for erections, a placebo-controlled study of desire and when to talk to someone.
Trulicity® and sexual functionTrulicity® and palpitations
Average pulse rise, fast-rhythm reports, the ECG change the labels describe and the signs that need urgent care.
Trulicity® and palpitationsTrulicity® and your period
What the labels say about the cycle and the pill, a PCOS trial, reporting data and when a change needs a doctor.
Trulicity® and menstrual changesTrulicity® and mood changes
No mood warning in any Trulicity® label. What the FDA’s 2026 review found, how low blood sugar can feel like a mood swing, and where to get help fast.
Trulicity® and mood changes
Foundayo™: side effects by symptom
Nausea on Foundayo™
The top row of the label’s safety table, two weight trials pulled apart, a head-to-head with oral semaglutide and the reason the dose climbs in 30-day steps.
Foundayo™ and nauseaVomiting on Foundayo™
The reaction that rose most with the dose, the rare serious cases in the registries, and why the label watches fluids so closely.
Foundayo™ and vomitingDiarrhea on Foundayo™
A common reaction with a high placebo rate, two trials that disagree on that rate, other causes, NIH advice on fluids and the kidney warning.
Foundayo™ and diarrheaConstipation on Foundayo™
The second most common reaction, an odd dose pattern, the few serious bowel cases in the trials and the warning signs of a blockage.
Foundayo™ and constipationHeartburn and indigestion on Foundayo™
Two rows of the label table, a peak at 9 mg, a head-to-head trial with oral semaglutide and an acid-reducer finding.
Foundayo™ and heartburnBloating and gas on Foundayo™
Distension and gas in the label and trial registries, the oral semaglutide comparison, everyday causes, self-care and when a swollen belly is urgent.
Foundayo™ and bloatingBurping on Foundayo™
A modest rate with the widest gap over placebo in the label table, how it compares with oral semaglutide, and what general sources say helps.
Foundayo™ and burpingStomach pain on Foundayo™
A common reaction in the label table, two separate terms in the trial registries, and the pain patterns that should not be waited out.
Foundayo™ and stomach painHeadache on Foundayo™
One of the most common reactions on paper, with the narrowest gap over placebo, two label warnings that can sit behind it and the signs that need urgent care.
Foundayo™ and headacheFatigue on Foundayo™
A non-digestive reaction that climbs with the dose, why the registries show lower numbers, and the ordinary causes worth ruling out.
Foundayo™ and fatigueDizziness on Foundayo™
A small gap in dizziness, a clearer one in low blood pressure, what blood pressure tablets change, the low-sugar overlap and the red flags.
Foundayo™ and dizzinessHair loss on Foundayo™
A small overall rate that looks very different in women and men, the label’s link to weight loss, and what the trial registries and general sources add.
Foundayo™ and hair lossLow blood sugar on Foundayo™
Uncommon on its own, more frequent with a sulfonylurea, and what the diabetes trials with and against insulin add.
Foundayo™ and low blood sugarGallbladder problems on Foundayo™
Small numbers, a formal warning, the serious cases in the trial registries and the label’s explanation that weight loss is the link.
Foundayo™ and the gallbladderPancreatitis and Foundayo™
Rare confirmed cases, the serious cases in each registry, a meta-analysis, a measured enzyme rise and a clear instruction if symptoms appear.
Foundayo™ and pancreatitisFoundayo™ and the kidneys
A warning about fluid loss more than the kidneys themselves, the serious cases in the registries, kidney disease and dose, kidney tests and warning signs.
Foundayo™ and the kidneysFoundayo™ and decreased appetite
Why the label treats a smaller appetite as the way the tablet works, what the trial registries counted, and when to call.
Foundayo™ and decreased appetiteFoundayo™ and taste changes
The label’s single dysgeusia line, the handful of cases in other trials, and the many non-drug reasons food can taste wrong.
Foundayo™ and taste changesFoundayo™ and hiccups
Not a labelled side effect, a few registry cases, the label’s nearby stomach reactions, and the two-day rule for calling.
Foundayo™ and hiccupsFoundayo™ and brain fog
Not in the label, single cases in trial registries, and the low sugar, fluid and blood pressure effects that can fog thinking.
Foundayo™ and brain fogFoundayo™ and body aches
What the trial registries show for joints, back and muscles, the label’s dysesthesia line, and its simvastatin interaction.
Foundayo™ and body achesFoundayo™ and insomnia
What the registries show for sleep, the label reactions that can wake you at night, and the sleep apnoea trial still under way.
Foundayo™ and insomniaFoundayo™ and rash
The label’s allergy warning and rate, the few skin events in trial registries, and the signs that mean stopping the tablet.
Foundayo™ and rashFoundayo™ and dry mouth
A rare registry entry, the label’s dehydration warning, common medicine causes and simple mouth care from the NIH.
Foundayo™ and dry mouthFoundayo™ and bad breath
Not in the label, one registry case, and four listed stomach reactions that can reach the mouth. Plus the breath smells that need urgent care.
Foundayo™ and bad breathFoundayo™ and frequent urination
Not listed in the label and rare in trials. The usual explanations, urinary infections in the registries, and why passing less urine is the change to watch.
Foundayo™ and frequent urinationFoundayo™ and kidney stones
Not in the label, a few stone events in the trial registries on both tablet and placebo, the dehydration link and how stone pain differs from the label’s warnings.
Foundayo™ and kidney stonesFoundayo™ and dental problems
No dental side effect in the label, a scattering of dental events in the trial registries, the acid and saliva routes, and the sedation warning that matters at the dentist.
Foundayo™ and dental problemsFoundayo™ and blood clots
No clot warning in the label, a few serious clot events in the registries on tablet and placebo, a heart safety trial, and label effects that can mimic clot symptoms.
Foundayo™ and blood clotsFoundayo™ and palpitations
The label’s tachycardia rate and pulse change, how orforglipron compared with oral semaglutide, and the warning signs.
Foundayo™ and palpitationsFoundayo™ and your period
No menstrual side effect in the label, a few cycle entries in the trial registries, the label’s pill and pregnancy rules, and the many other reasons a cycle shifts.
Foundayo™ and your periodFoundayo™ and mood changes
No psychiatric warning in the label, the FDA’s 2026 class review, what the trials recorded, and crisis help.
Foundayo™ and mood changes
Brand names are trademarks of their owners and are used only to identify the medicines. PepLabo is not affiliated with or endorsed by any manufacturer.
Set up your lab tonight.
It takes a few minutes. Pep will be waiting.